United States Medical Devices Views


Covidien And Mallinckrodt Part Ways

As a stand-alone company, Mallinckrodt could achieve annual revenue upwards of US$2 billion year-on-year, as it offers a very specialised and high-end drug portfolio. However, the company could...

Read article ›


Filter results

By Geography

By Sector

By Information Type